American drug wholesaler formed in 2001 from a Bergen Brunswig and AmeriSource merger
The U.S. Department of Justice and Walmart have reached a settlement over claims that Walmart pharmacies violated the Controlled Substances Act by failing to report red flags tied to opioid prescriptions. Walmart has not admitted liability. The settlement resolves claims from 2013 onward, with earlier related actions already settled in 2022. Walmart shares edged higher after the announcement.